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GIVING PHARMACEUTICAL MANUFACTURERS A PILL TO
SWALLOW: WHY NORTH CAROLINA SHOULD PROVIDE
DISCOUNT PRESCRIPTION DRUGS TO NON-ELDERLY
UNINSURED CITIZENS
VADDRICK Q. PARKER*

INTRODUCTION

This casenote discusses the potential impact of the United States
Supreme Court decision in PharmaceuticalResearch and Manufacturers of America (PhRMA) v. Walsh 1 on the State of North Carolina's
ability to provide discounted prescription drugs to its 1,125,480 uninsured residents. More specifically, the Supreme Court's decision will
be examined with respect to North Carolina's 880,240 nonelderly uninsured residents that fall between the ages of 19-64. Until May 19,
2003 there was no United States Supreme Court decision that allowed
states, via the federal Medicaid Act, to force pharmaceutical manufac-

turers to provide discounted prescription drugs for state residents that
did not qualify for the Medicaid program.
North Carolina currently has 1,122,898 nonelderly uninsured residents that fall below the federal poverty level.2 Persons in poverty
are defined as those who make less than 100percent of the Federal

Poverty Level (FPL), referred to as the poverty threshold.3 Studies
have shown that total pharmaceutical spending in the United States

* Third-year law student, North Carolina Central University School of Law (Durham,
North Carolina 2004).
1. Pharm. Research & Mfrs. of Am.v. Walsh, 538 U.S. 644 (2003). Pharmaceutical manufacturers association brought an action challenging the constitutionality of a Maine Act that
established fairer pricing for prescription drugs. The Supreme Court, Justice Stevens, held that
(1) the district court order preliminarily enjoining State of Maine from implementing its prescription drug rebate program, as allegedly preempted by federal Medicaid law, was an abuse of
discretion; and (2) Maine's prescription drug rebate program, under which enrollees could
purchase prescription drugs from participating Maine pharmacies at discounted price, with the
discount reimbursed out of rebate payments collected from participating drug manufacturers,
and under which any drug manufactured by nonparticipating manufacturer could not be dispensed to Medicaid beneficiaries without prior approval of State Medicaid administrator, did not
impose disparate burden on out-of-state manufacturers in violation of Commerce Clause. Id.
2. North Carolina: Distribution of NONELDERLY Uninsured by FederalPoverty Level,
Kaiser Family Foundation State Health Facts Online. Data Source: Urban Institute and Kaiser
Commission on Medicaid and the Uninsured based on pooled March 2001 and 2002 Current
Population Surveys, available at http://www.statehealthfacts.kff.org.
3. Id. "The federal poverty level for a family of three was $13,738 in 2000 and $14,128 in
2001." Id.
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topped $141.8 billion in 2001, and increased to an estimated $160 billion in 2002.' United States spending for prescription drugs is expected to continue to rise rapidly, reaching $445.9 billion (17percent
of personal health care spending) by 2012.1
Past North Carolina state legislation affecting prescription drug
prices has been focused primarily on providing discounted prescription drugs for children and the elderly. If North Carolina chooses to
act, as did Maine, North Carolina will be joined by a dozen other
states that are considering required prescription discounts to qualified
state residents.6
BACKGROUND

Maine's Proposed Prescription Drug Plan (Rx Plan/Program)
Under Maine's Rx program, all qualified uninsured Maine residents
would have access to discounted prescription drugs. This is made possible because Maine will pay for the discounts using rebates it gets
from the drug makers that participate in the Medicaid program. If a
company elects not to pay the rebate, Maine will require doctors to
get prior authorization from the state before prescribing that company's drug for Medicaid recipients. Opponents of the Maine Rx program argue that a program such as this would create a cumbersome
process that could prevent Medicaid patients from receiving necessary
prescription drugs. In addition, the brand name drug manufacturers
could suffer revenue losses due to the prior authorization procedure.
In 2000, Maine's state legislature established the Maine Rx Program.7 Maine's Rx program is unique because it seeks to assist all
qualified residents of the state regardless of their income level or socioeconomic status. Pursuant to Me.Rev.Stat. Ann. tit. 22, § 2681, the
state shall act as a pharmacy benefit manager in order to make prescription drugs more affordable for qualified Maine residents, thereby
increasing the overall health of Maine residents, promoting healthy
communities and protecting the public health and welfare.' If a pharmaceutical manufacturer chooses not to enter into a rebate agreement 9 there are two consequences for this nonparticipation. First, the
4. Pharmaceuticals:State Policy Overview At a Glance, National Conference of State Legislatures (June 1, 2003), available at http://www.ncsl.org/programs/health/pharm.htm.
5. Prescription Drug Trends, Kaiser Family Foundation (March 2003), available at http://
www.kff.org.
6. Joan Biskupic, Justices Clear Way For Plan That Cuts Prescription Costs, USA TODAY,
May 19, 2003.
7. Me.Rev.Stat. Ann., tit. 22, § 2681 (2003).
8. Id.
9. Pursuant to § 2681, "a drug manufacturer or labeler that sells prescription drugs in the
state of Maine through the elderly low cost drug program under section 254 or any other publicly
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names of the manufacturers and labelers who do not enter into rebate
agreements become public information, and the names of these companies will be released to both health care providers, and to the pub-

lic. 1° Second, the department shall impose prior authorization"
requirements in the Medicaid program, as permitted by law, for the
dispensing of prescription drugs provided by those manufacturers and
labelers.12
To avoid abuse by Maine residents, the state legislature proposed

limitations on the plan, and made access limited to individuals who do
3
not have a comparable or superior prescription drug benefit plan.'
Despite the fact that Maine seeks affordable prescription drugs for all

of its residents, it is clear that the state does not want to discourage
employers from providing prescription drug benefits.

4

The Medicaid Act
Medicaid is a joint federal and state program that seeks to provide

medical services to those whose income and resources are insufficient
to meet the costs of necessary medical services. 5 Congress created
the Medicaid program in 1965 by adding Title XIX to the Social Se-

curity Act. 6 The program authorizes federal financial assistance to
states that choose to reimburse certain costs of medical treatment for
needy persons. A state must, in order to participate in the Medicaid
program, have a plan for medical assistance approved by the Secretary
of Health and Human Services of that state. 7 In 1990 Congress required drug companies to pay rebates to states on their Medicaid prescription drug purchases. Prior to 1990, the Medicaid statute did not
specifically address outpatient prescription drug coverage. In an
amendment contained in the Omnibus Budget Reconciliation Act
(OBRA) of 199018 Congress ratified the Secretary of Health and
supported pharmaceutical assistance program shall enter into a rebate agreement with the department for this program." Id.
10. tit. 22, § 2681.
11. The proposed rules also explain that Maine will appoint a "Drug Utilization Review
Committee" composed of physicians and pharmacists who will evaluate each drug manufactured
by a company that has declined to enter into a rebate agreement to decide whether it is clinically
appropriate to subject the drug to prior authorization.
12. tit.
22, § 2681.
13. Id.
14. Id. "It is not the intention of the State to discourage employers from offering or paying
for prescription drug benefit plans that provide benefits comparable to those made available to
qualified Maine residents under this subchapter." Id.
15. See, 42 U.S.C. § 1396 (2003).
16. Title XIX appears in the United States Code as §1396-1396v, subchapter XIX, chapter
7, Title 42. Regulations relating to Title XIX are contained in chapter IV, Title 42, and subtitle
A, Title 45, Code of Federal Regulations.
17. See, 42 U.S.C. § 1396a(b) (2003).
18. 104 Stat. 1388-143 (1990).
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Human Services practice of approving state plans containing prior authorizations.1 9 Under this new amendment there were two basic
parts. First, in order to qualify for Medicaid payments, drug companies must enter into agreements either with the Secretary or, if authorized by the Secretary, with individual states, to provide rebates on
their Medicaid sales of outpatient prescription drugs.2 ° Second, once
a drug manufacturer entered into a rebate agreement the law required
the state to provide coverage for that drug under its plan unless the
state complied with
one of the exclusion or restriction provisions in
21
the Medicaid Act.
Under the 1990 OBRA, a state may subject a covered outpatient
drug to prior authorization,2 2 so long as the state's prior authorization
program (1) provides a response by telephone or other telecommunication device within 24 hours of a request for prior authorization, and
(2) except for the listed excludable drugs, provides for the dispensing
of at least a 72-hour supply of a covered drug in an emergency situation. The 1993 amendment to the OBRA reenacted the provisions
for state prior authorization programs that had been included in the
1990 OBRA.
THE CASE

Pharmaceutical Research and Manufacturers of America v. Walsh
The United States Supreme Court made it clear that the holding in
this case will not determine the validity of Maine's Rx program. 24 According to the Supreme Court, Maine's Secretary of Health and
Human Services could view the Maine Rx program as an amendment
to the state's Medicaid plan, therefore requiring the Secretary's approval before the program could become effective.2 5
In a 6 to 3 decision, the Supreme Court affirmed the Court of Appeals ruling, which stated that the lower court 26 was incorrect in hold19. See, e.g., Dodson v. Parham, 427 F.Supp. 97, 100-101 (N.D.Ga. 1977). Prior to this
amendment under plans approved by the Secretary, some state's designed and administered
their own formularies, listing the drugs that they would cover. States also employed "prior authorization programs" that required approval by a state agency to qualify a doctor's prescription
for reimbursement. Id.
20. If the state determines that a drug is essential to the health of a beneficiary, if it has
been given a special rating by the Federal Food and Drug Administration, and if a doctor has
obtained prior authorization for their use, the statute authorizes payment for the drug even if it
is not covered by a rebate agreement. See, 42 U.S.C. § 1396r-8(a)(3) (2003).
21. See Id., 42 U.S.C. § 1396r-8(d) (2003).
22. Id. at § 1396r-8(d)(1)(a).
23. Id. at § 1396r-8(d)(5).
24. Pharm. Research & Mfrs. of Am. v. Walsh, 123 S.Ct. 1855, 1866 (2003).
25. Id. at 1866.
26. The federal district court held that the Medicaid Act pre-empted Maine's Rx program
insofar as it threatened to impose a prior authorization requirement on nonparticipating manu-
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ing that Maine's Rx program was preempted by the federal Medicaid
law. The Supreme Court agreed with two of the three reasons given

by the Court of Appeals as to why preemption was incorrect. First,
since the federal statute expressly authorized the use of prior authorizations, it found "no conflict between the Maine Act and Medicaid's
structure and purpose. '' z7 Second, given the absence of an actual con-

flict, the court found that the mere fact that Maine Rx program "fails
to directly advance the purpose of the federal program" is an insufficient basis for "inflicting the 'strong medicine' of preemption" on
state statutes.18 The Court of Appeals also reviewed the affidavits
submitted in the case and concluded that they fell short of establishing
that the Maine Rx program will inflict inevitable or even probable

harm on Medicaid patients and thus were insufficient to support a preemption based facial challenge. 9
PhRMA had the burden of establishing by a clear showing that
there was no Medicaid related goal or purpose served by the Maine
Rx program, which it failed to do.3" The Supreme Court held that

there are three such goals plainly present in the Maine Rx program.
First, the program will provide medical benefits to persons who can be

described as "medically needy" even if they do not qualify for AFDC
or SSI benefits.3 ' Second, Medicaid expenses may be reduced by enabling some borderline aged and infirm persons better and earlier access to prescription drugs.3 2 Third, Medicaid's purpose will be
fostered whenever it is necessary to impose the prior authorization
requirement on a manufacturer that refuses to participate.3 3

facturers. The court assumed that the "Department of Human Services will not deny a single
Medicaid recipient access to the safest and most efficacious prescription drug therapy indicated
for their individual medical circumstances." Civ. No. 00-157-B-H (D.Me., Oct. 26, 2000), App.
to Pet. for Cert. 68. In the district courts view, since Maine altered the federal Medicaid program to serve Maine's local purposes that act alone was outside the scope of the Medicaid program and created an obstacle to the administration of the federal program and therefore was
preempted by federal law. Id.
27. Pharm. Research & Mfrs. of Am. v. Walsh, 249 F.3d 66, 75 (C.A.1 Me 2001). In its view,
as long as there was compliance with the federal 24- and 72-hour conditions, the State's motivation for imposing the requirement is irrelevant. Id.
28. Id. at 76.
29. Id. at 78.
30. Pharm. Research & Mfrs. of Am. v. Walsh, 123 S.Ct. 1855, 1867 (2003).
31. Id. "Even if the program is more inclusive than the Secretary thinks it should be, the
potential benefits for nonneedy persons would nullify the benefits that would be provided to the
neediest segment of the uninsured population." Id.
32. Id. "If members of this borderline group are not able to purchase necessary prescription
medicine, their conditions may worsen, causing further financial hardship and thus making it
more likely that they will end up in the Medicaid program and require more expensive treatment." Id. at 1867-88.
33. Id. at 1868. "Private managed care organizations typically require prior authorization
both to protect patients from inappropriate prescriptions and to encourage the use of cost effective medications without diminishing safety or efficacy." Under current law, States would have
the option of imposing prior authorization requirements with respect to covered prescription

Published by History and Scholarship Digital Archives, 2004

5

North Carolina Central Law Review, Vol. 26, No. 2 [2004], Art. 5

2004]

A PILL TO SWALLOW

The fact that the Maine Rx program may serve Medicaid related
purposes, both by providing benefits to needy persons and by curtailing the state's Medicaid costs, would not provide a sufficient basis
for upholding the program if it severely curtailed Medicaid recipients'
access to prescription drugs.3 4 States have substantial discretion to
choose the proper mix of amount, scope, and duration limitations on
coverage, as long as care and services are provided in the best interest
of the recipients.35 The fact that a state's decision to curtail Medicaid
benefits may have been motivated by a state policy unrelated to the
Medicaid Act does not limit the scope of its broad discretion to define
the package of benefits it will finance.36 The need to protect the
health of the uninsured residents in Maine provides a plainly permissible justification for a prior authorization requirement that is assumed
to have only a minimal impact on Medicaid recipients' access to prescription drugs.3 7
The impact on patient care and access to appropriate drugs far outweighs any adverse impact on the manufacturers of brand name prescription drugs. Under this Supreme Court ruling, the impact on
brand name pharmaceutical manufacturers is irrelevant because the
transfer of business to less expensive products will produce savings for
the Medicaid program.38 Until such time when patient care is directly
affected by the prior authorization requirement, the severity of any
impediment that Maine's program may impose on a Medicaid patients' access to the drug of her choice is a matter of conjecture, and
the Court could not conclude that any patient's medical needs would
be adversely affected based on the record before it. 39 The Court also
concluded that the Maine's Secretary of Health and Human Services
is likely to take action with respect to the Maine Rx program, and
until such time the fate of the Maine Rx program would remain
unknown.4 0
ANALYSIS

Overview of Prescription Drug Prices
Spending for prescription drugs is one of the fastest growing
drugs in order to safeguard against unnecessary utilization and assure that payments are consistent with efficiency, economy, and quality of care. H.R.Rep. No. 101-881, p. 98 (1990),
U.S.Code Cong. & Admin.News 1990, pp. 2017, 2110.
34. See, 42 U.S.C. § 1396a (a)(19) (2003).
35. Alexander v. Choate, 469 U.S. 287, 303, 105 S.Ct. 712, 83 L.Ed.2d 661 (1985).
36. See, Beal v. Doe, 432 U.S. 438, 97 S.Ct. 2366, 53 L.Ed.2d 464 (1977).
37. Pharm. Research & Mfrs. of Am. v. Walsh, 123 S.Ct. 1855, 1869 (2003).
38. Id. at 1870.
39. Id.
40. Id.
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components of health care.4 1 About 23 million American adults, or 12

percent of the adult population, could not afford to get at least one
needed prescription medication in 2001, according to the 2000-2001

Community Tracking Study (CTS) household survey. While most
nonelderly adults have prescription drug coverage through employer

sponsored health insurance, or the Medicaid program, over 26 million
Americans lack health insurance for any kind of medical care.42

Based on these facts, there is evidence that an even greater number of
nonelderly adults are vulnerable to cost barriers to prescription medications, either due to a complete lack of health care coverage, or limitations in Medicaid prescription drug coverage relative to the needs of
the beneficiaries.4 3 In addition, prescription costs paid by those without prescription drug insurance was on average about 15percent

higher than those with insurance in 1996.44
Three main factors are driving the increases in prescription drug
spending. The first factor is the increasing number of prescriptions,
which is responsible for 47percent of the overall increase in prescrip-

tion spending from 1997-2001. 4" Second, the changes in the types of
drugs used, which accounted for 27percent of the increase.4 6 Third,

manufacturer price increases for existing drugs, which accounted for
26percent of the increase.4 7 Despite the fact that there is increased

spending, especially on newer and more advanced pharmaceuticals,
there is growing evidence that these drugs save money on other health
care services.48
The Potential Impact of the Walsh Decision on the State of North

Carolina
North Carolina's Medicaid program 49 mirrors the Medicaid pro-

gram of most other states by attempting to address the health and
41. Prescription Drug Trends, Kaiser Family Foundation (March 2003), available at
www.kff.org. " Although prescription drug spending is a relatively small portion (11percent) of
personal health care spending, it is one of the fastest growing components, increasing at doubledigit rates in each of the past 7 years." Id.
42. Peter J.Cunnigham, Ph.D, Affording Prescription Drugs: Not Just a Problem for the
Elderly, Research Report No. 5 (April 2002).
43. Id.
44. PrescriptionDrug Trends, Kaiser Family Foundation (March 2003).
45. Id.
46. Id. "With newer, higher priced drugs replacing older, less expensive drugs." Id.
47. Id.
48. The Best Value in Medicine Today: How PrescriptionDrugs Account for a Fraction of
Health Cost Increases While Helping to Offset Other Health Costs, Pharmaceutical Researchers
and Manufacturers of America (2003).
49. North Carolina Division of Medical Assistance, available at www.dhhs.state.nc.us/dma.
Typically, "to be eligible for Medicaid you must be (i) age 65 or older OR Under 65 and unable
to work due to a severe disability that is expected to last at least 12 months, (ii) have a monthly
income no greater than $749 for individuals or $1010 for couples (income includes Social Secur-
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long-term care needs of the low income disabled and elderly populations, and their families. As required by the Medicaid Act, all states

must have a state plan that is approved by the Secretary of Health and
Human Services. Title XIX of the Social Security Act requires that

North Carolina provide a plan to administer and manage the North

Carolina Medicaid program.5 0 In addition to providing the amount,
scope, and duration of services as well as eligibility requirements, the
North Carolina plan outlines 5the
organization and function of the Di1
vision of Medical Assistance.

North Carolina's plan is consistent with the 1990 Omnibus Budget
Reconciliation Act and its 1993 amendment, which permits the use of
prior authorization for pharmaceutical manufacturers that have not
entered into a rebate agreement with the State of North Carolina.52
North Carolina's plan also provides for a response by telephone or
other telecommunication device within 24-hours of a request for prior
authorization, as well as the dispensing of at least a 72-hour supply of
a covered outpatient prescription drug in an emergency situation.5 3
North Carolina has implemented Senior Care and North Carolina

Health Choice (NCHC). These programs seek to administer prescription drugs to seniors and children, respectively. Senior Care offers a

traditional drug benefit that covers sixty percent of the first thousand
dollars worth of the cost of prescription drugs and insulin for the

treatment of cardiovascular disease, chronic obstructive pulmonary
disease and/or diabetes, while program members pay the remaining
forty percent of the cost for covered drugs, and six dollars for each 30day prescription.5 4
ity, Veteran's Benefits, pensions, etc.) and (iii) resources must be no more than $2,000 for an
individual, or $3,000 for a couple. Resources include cash, bank accounts, second car, retirement
accounts stocks, real estate etc." Id.
50. North Carolina Division of Medical Assistance. Administrative and Regulatory Affairs
(June 11, 2002).
51. Id. The Division of Medical Assistance is a subset of the North Carolina Health and
Human Services Department.
52. Memorandum from Portia W. Rochelle, North Carolina state plan coordinator to state
plan e-mail subscribers (August 9, 2002) (on file with author). Section 12(a) Prescribed Drugs
Attachment 3.1-A.1 p. 14. "Drugs for which medical Assistance reimbursement is available are
limited to the following: (4) Covered outpatient drugs of any manufacturer which has entered
into and complies with an agreement under Section 1927(a) of the Act which are prescribed for a
medically accepted indication. In addition, prior authorization must be obtained from the Medicaid agency or its authorized agent for any drug on the prior authorization list before Medicaid
reimbursement is available." Id.
53. Id.
54. North Carolina Senior Care Program-ProgramBenefits (June 5, 2003) available at
http:// www.ncseniorcare.com/programBenefits.htm. "Any costs beyond the $600 covered by the
program and cost for drugs that treat illnesses not covered by Senior Care are the member's
responsibility." Id.
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NCHC is a fee-for-service insurance program that provides free or
low-cost health coverage, including prescription drugs, to children
under the age of nineteen whose families cannot afford private health
insurance and that do not qualify for Medicaid.55 Unfortunately,
there is no comparative program for North Carolina's uninsured
nonelderly adult residents.

North Carolina's number of uninsured nonelderly residents is reported based on information from two general surveys, each controlled by a different independent variable. The first survey was
controlled by the federal poverty level,56 and the second was controlled by the population distribution by insurance status. North Carolina has a total population of 8,049,313." 7 As stated in the
introduction, North Carolina has 1,122,898 nonelderly uninsured residents that fall below the federal poverty level.5 8 Based on these
numbers approximately 13.95 percent of North Carolina's population
fall below the federal poverty level. A second survey, also conducted
by the Kaiser Foundation, shows that approximately 1,125,480, or
13.98 percent of North Carolinians are uninsured.5 9
As indicated, North Carolina provides health and prescription drug
programs for children and the elderly. This casenote focuses on those
between the ages of 19 to 64 that are not provided with prescription
55. North Carolina Division of Medical Assistance, North Carolina Health Choice Frequently Asked Questions for Pharmacists (June 10, 2003) available at http://
www.dhhs.state.nc.us/dma/CHIP/faq/pharmfaq.htm. "The program was established in October
1998 by the federal government and the state of North Carolina. It is modeled after the State
Teachers' and Employees' Comprehensive Major Medical Plan and is administered by
BlueCross and BlueShield of North Carolina (BCBSNC) with the exception of pharmacy benefits, which are managed by AdvancePCS ... Coverage includes "acute care", preventative care
services, hospitalization, prescription drugs, durable medical equipment, medical supplies, and
special hearing and vision benefits." Id.
56. The results in this survey were based on the federal poverty level for a family of three in
2000, which was $13,738, and 2001, which was $14,128. The federal poverty guidelines for 2003
are as follows: for an individual the amount is $8,980, for a couple the amount is $12,120, family
of three the amount is $15,260 and for a family of four the amount is $18,400. 68 Fed. Reg.
6456-58 (February 7, 2003).
57. U.S. Census Bureau, census 2000 profile of general demographic characteristics for
North Carolina.
58. The Henry J. Kaiser Family Foundation State Health Facts Online, North Carolina:Distribution of Nonelderly Uninsured by FPL, state data 2001-2002, U.S. 2002, available at http://
www.statehealthfacts.kff.org. "Those individuals who fall under 100percent of the FPL equals
411,563 (37percent of the 1,122,898). Those individuals who fall between 100-199percent equals
314,202 (28percent of the 1,122,898). Those who fall 200percent or more below the federal poverty level equals 397,132 (35percent of the total 1,122,898)." Id.
59. North Carolina:Population Distribution by Insurance Status, Kaiser Family Foundation
State Health Facts Online. Data Source: Urban Institute and Kaiser Commission on Medicaid
and the Uninsured based on pooled March 2001 and 2002 Current Population Surveys, available
at http:// www.statehealthfacts.kff.org. The disparity between the 1,122,898 reported as falling
below the federal poverty level and the 1,125,480 reported as being uninsured could be due to an
instance where a resident is uninsured, yet does not fall below the federal poverty level for
whatever reason.
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coverage. North Carolina has 4,886,905 residents that are
nonelderly, 6° of which 880,240 are uninsured. 61 Therefore, approximately 18.01 percent of all North Carolina residents between the ages
of 19-64 are uninsured. The percentage of uninsured nonelderly is 4.03
percent higher than the total percentage of uninsured residents for the
entire state, which is 13.98 percent. It is likely that the vast uninsured
nonelderly that lack health insurance also lack prescription coverage.
The growing number of uninsured residents is a concern not only of
the citizens, but also for politicians in North Carolina. In the August
2000 Congressman Robin Hayes served as a conference chair for the
North Carolina Regional Healthcare Forum. At this forum Roy Hinson of Stanly Memorial Hospital noted that a lack of insurance ranked
second behind a language barrier, as the biggest healthcare concern in
North Carolina.62 Congressman Richard Burr, representing North
Carolina's 5th Congressional District, also noted that North Carolina
faces a serious problem in providing quality and affordable health
care to its residents.63 Congressman Burr's reasoning was that high
insurance costs is the reason for the increased number of uninsured
residents in North Carolina', albeit directly reflecting the rising cost
of prescription drugs. Congressman Burr proposed that Congress
continue to do three things to provide North Carolina citizens with
greater access to affordable, high quality health care. First, ensure
that employers have the proper incentives to provide health care. 65
Second, look at alternative solutions that may reduce the number of
uninsured and underinsured.66 The Walsh decision could be a start to
thinking about alternative solutions by providing affordable prescription drugs that may prevent existing medical conditions frbm worsening. Third, increased support for community health care centers
across North Carolina.67
North Carolina currently provides affordable prescription drugs to
the nonelderly uninsured residents through federally qualified community health centers (FQHCs), charitable foundations, and phar60. U.S. Census Bureau, census 2000 profile of general demographic characteristics for
North Carolina.
61. North Carolina: Distribution of Adults 19-64 by Insurance Status, The Kaiser Family
Foundation State Health Facts Online. Data Source: Urban Institute and Kaiser Commission on
Medicaid and the Uninsured based on pooled March 2001 and 2002 Current Population Surveys,
available at http:// www.statehealthfacts.kff.org.
62. Roy Hinson, Address at the North Carolina Regional Healthcare Forum in Concord,
North Carolina. (April 19, 2000).
63. Congressman Richard Burr, North Carolina Political Review: Expand Health Centers
(August 2002) available at www.ncpoliticalreview.com.
64. Id.
65. Id. "Majority of health care plans are provided by employers." Id.
66. Id.
67. Id.
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macy assistance programs. [For purposes of this casenote, health care
centers will be discussed in a manner that details the impact such centers have on prescription drug access, as opposed to general health
care.]

In 2001, North Carolina's 20 community health centers cared for
more than 700,000 North Carolinians. FQHCs are vital sources of primary health care for underserved populations in North Carolina, providing cost effective quality care for our most vulnerable men, women
and children.6" A FQHC must adjust its fees based on a patient's income and family size, and it cannot refuse service because an inability
to pay.6 9 [The services that are included in primary care may include
prescription drugs.] However, since FQHCs funding sources 70 are
limited and focused on new patients and new services, the health cen-

ters are not being compensated for increased cost, including prescription drug costs, and the rising burden of uncompensated services.71
This places a heavy financial burden on North Carolina's community
health centers.

Charitable foundations can play several roles in improving access to
prescription drugs for North Carolina's nonelderly uninsured residents. For example, the Kate B. Reynolds Charitable Trust in Winston-Salem, North Carolina has provided funding for a variety of

pharmacy programs since 1995 by awarding grants to health clinics
and health departments. These grants are used to purchase medica-

tions, hire staff to work with prescription assistance programs, and salary support for pharmacists. 72 This method ultimately leads to greater
68. North Carolina'sHealth Centers: "Standing in the Gap", North Carolina Primary Health
Care Association (March 2003).
69. Id. "Fees that are unable to be collected are referred to as 'bad debt'. During the
period 1998-2001, bad debt losses rose by 62 percent and is projected to show even more significant losses for 2002."
70. "Grants from the Bureau of Primary Health Care provide less than 30 percent of the
total support needed to operate a health center. The balance must come from patients service
revenues through Medicaid, Medicare, and private insurance... Many FQHCs have historically
used revenue from other patients, such as Medicaid, to offset some of the costs associated with
caring for the uninsured. However, the potential of increased managed care revenue has made
Medicaid more attractive to providers that have not traditionally served that population within
North Carolina. Consequently, many of North Carolina's community health centers have lost
Medicaid income and have fewer resources available for their uninsured patients. The total
effect is an increase in uninsured patients while the number of Medicaid patients seen at FQHCs
decreases." Id.
71. Id. "The President's Health Center Initiative focuses on new patients and new services.
No additional funding has been offered to health centers to compensate them for the increased
cost and the rising burden of uncompensated services. FQHCs have not received a cost adjustment to their base funding in two years. This leaves many health centers in North Carolina
bursting at the seams with patients, yet struggling payroll to payroll to maintain their operations." Id.
72. Access to PrescriptionMedicationsfor the Uninsured: Findingsfrom the Grantmakersin
Health Resource Center, Grant Makers Health (GIH Annual Meeting 2003).

Published by History and Scholarship Digital Archives, 2004

11

North Carolina Central Law Review, Vol. 26, No. 2 [2004], Art. 5

2004]

A PILL TO SWALLOW

access to prescription drugs. In addition to providing funding to
health clinics and health departments, charitable foundations have developed programs to fund co-payments for people who cannot afford
them.73
Several states have also developed pharmacy assistance programs
for their low-income populations funded from general revenues and
direct subsidies or discounts. Many of the existing prescription assistance programs fail to provide for the nonelderly by only providing
drug coverage for people ages 65 or older that do not have supplemental Medicare coverage.7 1 Often pharmaceutical companies provide medicines free of charge to consumers and to physicians whose
patients might not otherwise have access to necessary medicines.7 5
Most often, a patient's physician would refer them to the pharmaceutical assistance program or make an application on their behalf.76 The
Pharmaceutical Research and Manufacturers of America has compiled a directory of prescription drug patient assistance programs.
Compared to North Carolina, Maine has a total population of
1,274,923 of which 756,036 are nonelderly.7 7 Of the 756,036 between
the ages of 19 and 64, 113,090 are uninsured. 78 Therefore, approximately 14.95 percent of Maine's nonelderly residents are uninsured
compared to North Carolina's 18.01 percent. That equates to a 3.06
percent difference between the number of nonelderly uninsured residents in North Carolina as compared to Maine. If providing affordable prescription drugs was important to the State of Maine and its
residents, then it should be equally important for North Carolina.
Maine's prescription plan seeks to provide affordable prescription
drugs to all of its qualified residents. North Carolina could use this
same methodology to provide affordable prescription drugs to its
nonelderly uninsured residents. There are several reasons why North
Carolina should follow in Maine's footsteps. First, enacting a prescription drug plan consistent with Maine's prescription drug plan
would compliment North Carolina's Health Choice program for children and North Carolina's Senior Care program for the elderly,
73. Id. "The Health Foundation of Greater Cincinnati, for example, provided a grant to
establish a co-payment bank to provide co-payments for patients who were not able to fll prescriptions because they could not afford the co-payments." Id.
74. Id.
75. Pam Silberman, A Consumer's Guide to Health Insurance and Health Programs in
North Carolina (May 2003).
76. Id.
77. U.S. Census Bureau; census 2000 profile of general demographic characteristics for
Maine.
78. Maine: Distribution of Adults 19-64 by Insurance Status, Kaiser Family State Health
Facts Online, Data Source: Urban Institute and Kaiser Commission on Medicaid and the Uninsured estimates based on pooled March 2001 and 2002 Current Population Surveys available at
http:// www.statehealthfacts.kff.org.
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thereby providing affordable prescription drug access to a larger percentage of the population. Second, a prescription drug plan could
lower future health care costs by addressing serious health problems
at their outset, before the problems have a chance to worsen. Third, a
prescription drug plan would reduce the strain placed on North Carolina's community health centers. Finally, a prescription drug plan
would compliment pharmacy assistance programs, which usually cater
to older individuals.
If North Carolina were to enact a prescription drug plan similar to
Maine's Rx program, then it would compliment both North Carolina's
Senior Care program for the elderly, as well as NCHC. While NCHC
provides for children and Senior Care provides for the elderly, an independent prescription drug plan would provide for not only children
and seniors without a comparable or superior prescription drug plan,
but also for the nonelderly uninsured population. There are no age
limits under Maine's proposed plan79 , therefore unlike NCHC and Senior Care the nonelderly population would be allowed to purchase
prescription drugs at a discounted rate. This would in effect provide a
dual benefit.
Second, a prescription drug plan such as Maine's Rx program, could
possibly lower future health care costs in North Carolina. The Supreme Court noted the impact that such a plan could have on a state's
ability to lower future health care costs by ruling that it is possible to
lower Medicaid expenses by enabling some borderline aged and infirm persons better access to prescription drugs before their condition
worsen."0 If a patient's condition is allowed to worsen, it will inevitably lead to more expensive treatment. For the uninsured population
the worsening effect would mean increased reliance on state and government funding. By analogy, allowing better access to prescription
drugs for the borderline aged and infirm to reduce future medical
costs could also apply to the nonelderly uninsured residents of North
Carolina. By providing nonelderly uninsured residents of North Carolina better access to prescription drugs it would logically follow that
future health care costs among this group could be lowered. This theory is also supported by an article from the Pharmaceutical Researchers and Manufacturers of America in which it is stated that "there is
growing evidence that increased spending on medicines, especially

79. The most important limitation is the program would apply to those individuals who to
do have a comparable or superior prescription drug insurance plan.
80. Pharm. Research & Mfrs. of Am. v. Walsh, 123 S.Ct. 1855, 1867 (2003).
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pharmaceuticals, save money on other health
newer, more advanced
81
care services.
In Governor Mike Easley's 2003 State of the State Address he argued for, and encouraged preventive health care procedures for North
Carolina residents. Providing affordable prescription drugs to prevent
serious illnesses and diseases from worsening later in a patient's life
could very well serve this purpose. In many cases the preventative
health care procedure that Governor Easley mentioned is in fact preventative prescription drugs.
Third, providing a prescription drug plan similar to Maine's Rx plan
could also reduce the strain on North Carolina's community health
facilities. According to the North Carolina Primary Health Care Association, North Carolina health care centers are having financial
problems maintaining their operations.82 This is a direct result of
community health centers not being compensated for increased health
care cost and the rising burden of uncompensated services. The facts
also indicate that prescriptions drugs account for a large percentage of
health care expenses in past years. Therefore, if pharmaceutical companies were forced to comply with a prescription drug plan, such as
the Maine Rx plan, the cost of prescription drugs will decrease along
with a decrease in health care costs. The community health centers
would see a decline in prescription drug costs thereby easing the burden of payroll to payroll expenses.
Finally, a prescription drug plan similar to Maine's Rx plan would
compliment pharmacy assistance programs, which usually cater to
older individuals. Unlike the typical pharmacy assistance program,
which generally targets people ages 65 or older and most often requires a patient's physician to refer them to the pharmaceutical assistance program or make an application on their behalf, a prescription
drug plan would not limit an individual from receiving discount prescription drugs due to age or physician references. So long as the individual resident does not have a comparable or superior prescription
drug plan, then they are eligible to receive the discounted prescription
medication.
CONCLUSION

The United States Supreme Court ruling in Pharmaceutical Researchers and Manufacturers of America v. Walsh could have a posi81. The Best Value in Medicine Today: How PrescriptionDrugs Account for a Fraction of
Health Cost Increases While Helping to Offset Other Health Costs, Pharmaceutical Researchers
and Manufacturers of America (2003).
82. North Carolina'sHealth Centers: "Standing in the Gap", North Carolina Primary Health
Care Association (March 2003).
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tive impact on the State of North Carolina and its ability to provide
affordable prescription drugs to the 18.01percent of nonelderly uninsured residents between the ages of 19 and 64. If North Carolina were
to follow in Maine's footsteps and enact a prescription drug plan, that
plan would compliment North Carolina's Health Choice program and
North Carolina's Senior Care program, it could possibly lower future
health care expenses in North Carolina, the plan would reduce the
strain on North Carolina's community health facilities, and finally it
would compliment any existing pharmacy assistance program.
As noted above, the United States Supreme Court did not decide
whether the Maine Rx program was valid, only that it did not violate
the federal Medicaid Act. North Carolina's Secretary of the Department of Health and Human Services could view such a plan, if proposed, as an extension of the state's Medicaid plan. Therefore, the
Secretary's approval of such a plan would be required before it is held
to be valid. Walsh gives states the opportunity to provide affordable
prescription drugs under the guise of the federal Medicaid Act.
Opponents of the Maine Rx program will seek to prove that ultimately the Medicaid recipients will suffer because the individual states
will dictate what prescription medication will be subjected to prior authorization. Spokesperson for Pharmaceutical Researchers and Manufacturers of America, Marjorie Powell, stated that PhRMA feels that
the core issue under Maine's Rx program is that government officials
rather than doctors and patients will decide which medicines will be
available to patients and that a better solution is to pass a plan which
provides prescription drug benefits for seniors and disabled persons in
2003 because over 1400 brand name medicines are available free to
patients without prescription drug coverage through pharmacy assistance programs 83 and seniors qualify for a variety of discount programs.84 These comments by Powell came after the Supreme Court
effectively discounted PhRMA's contentions and ruled that despite of
these possible effects, there is no evidence to support such assertions.
Only time will tell if indeed Medicaid patients are being affected by
such a prescription drug program as Maine Rx. Until such time,
North Carolina should follow in Maine's footsteps and attempt to
force pharmaceutical manufacturers to lower prescription drug prices
for qualified state residents.

83. Previous findings show that these programs usually cater to older individuals.
84. Press Release, Marjorie Powell, spokesperson for PhRMA remarks regarding the Supreme Court's ruling in Pharm. Research & Mfrs. of Am. v. Walsh (May 19, 2003) (on file with
author).
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